News

Elizabeth Roulette Baseler Recognized as Pinnacle Professional for 2025

Elizabeth Roulette Baseler Recognized as Pinnacle Professional for 2025

Elizabeth Roulette Baseler Achieves Prestigious Recognition

In a commendable acknowledgment, Elizabeth Roulette Baseler has been named a 2025 Pinnacle Professional Member Inner Circle of Excellence for her exceptional contributions in the fields of healthcare and research. This recognition highlights her dedication and impactful work, marking an important milestone in her career.

Impressive Career and Contributions

Ms. Baseler is a distinguished leader in healthcare and clinical research with over 46 years of experience. Currently, she serves as a Senior Clinical Project Manager at Manpower, a role she has excelled in since 2023. Her impressive career was significantly shaped by her tenure at Leidos Biomedical Research Inc., where she advanced from 1978 until 2022, ultimately serving as the Director of Clinical Monitoring for the Research Program Directorate at the Frederick National Laboratory for Cancer Research.

Global Impact in Clinical Trials

Throughout her career, Ms. Baseler has played a pivotal role in establishing clinical infrastructure and ensuring regulatory compliance for clinical trials conducted by the National Institutes of Health. Her work has taken her to over 29 countries, where she has successfully set up clinical trials and led diverse teams in challenging healthcare environments. Notably, her contributions to the Ebola outbreak response in West Africa from 2014 to 2016 demonstrated her commitment to addressing global health crises.

Education and Professional Affiliations

Ms. Baseler is a proud alumnus of McDaniel College, where she earned her Bachelor's degree in Biology, and Hood College, where she completed her Master of Science in Administration and Management. She is affiliated with several esteemed professional organizations, including the Society of Clinical Research Associates and the Regulatory Affairs Professionals Society. Her passion for mentorship is evident through her active involvement with Woman to Woman Mentoring and contributions to initiatives like Blessings in a Backpack and the Ocean City Reef Foundation.

Recognitions and Future Aspirations

Her exemplary career has been recognized with prestigious awards, including the Directors Award from the NIH, along with accolades from the National Institute of Allergy and Infectious Diseases. Looking ahead, Ms. Baseler is eager to continue her growth in clinical research, expand her mentoring efforts, focus on women’s leadership, and share her experiences through writing.

Personal Values and Mentorship

Ms. Baseler attributes her success to the unwavering support of her family and mentors. She remains passionate about biology and clinical research while emphasizing the importance of networking, seeking advice, and effective public speaking in her career development.

Frequently Asked Questions

Who is Elizabeth Roulette Baseler?

Elizabeth Roulette Baseler is a prominent figure in healthcare and clinical research, recognized for her extensive experience and contributions to the field.

What is the Pinnacle Professional Member recognition?

The Pinnacle Professional Member recognition honors individuals for their outstanding achievements and contributions in their respective fields.

What roles has Ms. Baseler held in her career?

Ms. Baseler has served in various roles, including Senior Clinical Project Manager at Manpower and Director of Clinical Monitoring at Leidos Biomedical Research Inc.

In which areas has Ms. Baseler made significant contributions?

Ms. Baseler has made significant contributions to clinical infrastructure establishment, regulatory compliance, and response efforts for global health crises.

What are Ms. Baseler's future goals?

She aims to continue her growth in clinical research, enhance mentoring efforts, and share her knowledge through writing.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Musculoskeletal Market Wave: Non-Opioid Treatment Growth

Updated Category News Views 2

A Shift in Pain Management Tactics Look, it's about time the musculoskeletal pain market shook things up. The old reliance on opioids has become too risky, with dependency and misuse marking the territory. Now, the forecast between 2026 and 2036 is spinning a different tale, one that could see non-opioid approaches taking their place in the spotlight. Why Is This Such a...

Continue Reading
Life Insurance for $25/Month? Pacific Life Leads Pack

Updated Category News Views 9

The $25 Million-Dollar Question Imagine this: snagging a million-dollar life insurance policy for just about the cost of your morning coffee habit. That's the kind of deal Pacific Life is bringing to the table, according to the latest report from Quote.com. For $25 a month, that hefty life coverage isn't just a pipe dream—it's the real deal. We're talking less than what...

Continue Reading
SuperSprings & B&W Unite for Top Adapter Innovation

Updated Category News Views 4

A Game-Changer in Towing Adaptation You think swapping a fifth wheel for a gooseneck is easy-peasy? Not unless you've got an award-winning adapter on your hands. SuperSprings International and B&W Trailer Hitches have set the bar sky-high with their latest creation—a fifth wheel to gooseneck adapter making waves in the market. Winning Big in the RV Market This isn't...

Continue Reading
Enliven's ELVN-001: Eyeing New Frontiers in CML Treatment

Updated Category News Views 2

ELVN-001: A Glimpse into a New Era for CML They're saying Enliven Therapeutics is about to shake things up in the world of chronic myeloid leukemia (CML) with their latest presentation on ELVN-001. Now, if you're not familiar, this is the same stuff that got the spotlight at the European Hematology Association (EHA) 2026 Congress. What's the gut feeling here? Maybe we've...

Continue Reading
YFORE Advances UWB Radar: Safety and Precision

Updated Category News Views 16

YFORE's UWB Radar: Revolutionizing Vehicle Technology Out of Suwanee, Georgia, YFORE Technology is putting the pedal to the metal with its Ultra-Wideband (UWB) radar sensing capabilities. This isn't a run-of-the-mill innovation—it’s a blueprint for the next era of smart vehicles. The spotlight’s on their multi-scenario UWB radar portfolio that’s set to redefine...

Continue Reading
Hokkien Music Tour Revives an Ancient Maritime Tradition

Updated Category News Views 20

Breaking New Ground: Hokkien Concert in Huizhou Listen, there's something downright magical about watching a whole new chapter of culture unfold, especially when it’s as deep-rooted as Hokkien. Picture this: the Opera House in Huizhou jam-packed, not a single seat to spare. People wrapped around a tradition that's been breathing life into the world for over a thousand...

Continue Reading
Illinois Water Flushing: Essential But Inconvenient

Updated Category News Views 2

Kicking Off Another Round of Hydrant Flushing You know what marks the transition from summer to fall in Streator just as surely as the leaves changing color? That's right, hydrant flushing season, courtesy of Illinois American Water. Beginning September 1 and stretching through October 2, Illinois American Water is diving into their yearly ritual of flushing out the water...

Continue Reading
ADMA's Fiduciary Duty Under Siege by Legal Inquiry

Updated Category News Views 4

A Closer Look at ADMA's Legal Quandary Boy, it looks like ADMA Biologics is in hot water again. This time, it's the big dogs over at Berger Montague PC sniffing around. They're a heavyweight national law firm with a knack for taking on complex securities and class action cases. And now they've got their eyes on ADMA's Board of Directors for some alleged funny business....

Continue Reading
Ultra Violette Leads U.S. Sunscreen Revolution

Updated Category News Views 4

The sunscreen game in the U.S. just got a serious shake-up, thanks to Ultra Violette. This cult favorite from Down Under is taking no prisoners with its latest move, launching Unblock Screen™ SPF 50 right in the land of the free. But this ain't just another sunscreen—it's the first to bring Bemotrizinol (BEMT) to the U.S. after gaining the all-clear from the FDA....

Continue Reading
Nutex Health Wins Community Awards, Faces Big Risks

Updated Category News Views 11

Nutex Health Rides High on Community Approval You want to know how you earn the trust of a community? You deliver consistent healthcare that makes folks feel valued and respected. Nutex Health Inc. (NASDAQ:NUTX) didn't just toss a bone this quarter—they raked in a bunch of community honors that shout loud and clear: patients are at the heart of what they do. From...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming Insurance: Applied Systems' Acquisition of Cytora

Updated Category News Views 163

Applied Systems Expands Its Footprint with Cytora Acquisition In a strategic move to strengthen its position in the insurance technology sector, Applied Systems has announced the acquisition of Cytora, a pioneering digital risk processing platform. This acquisition marks a significant milestone in Applied's journey toward advancing the Next Generation of the Digital...

Continue Reading
ICG Enterprise Trust Reports Impressive Financial Growth

Updated Category News Views 220

Introduction to ICG Enterprise Trust's Interim Results ICG Enterprise Trust plc has published its unaudited interim results for the six months period ending 31 July 2025, revealing significant developments in the investment landscape. As a leading investor in private companies, ICG Enterprise Trust continues to navigate the complexities of financial investments...

Continue Reading
BTC Digital Ltd. Strengthens Market Position Through Offering

Updated Category News Views 113

BTC Digital Ltd. Enhances Financial Framework with Capital Raise BTC Digital Ltd. (NASDAQ: BTCT), a notable player in the blockchain technology sphere, has made headlines recently with an important financial maneuver. The company announced that its underwriter exercised an over-allotment option related to its public offering. This move allowed the company to sell an...

Continue Reading
Siili Solutions Unveils New Stock Options Program for 2025A

Updated Category News Views 370

Siili Solutions Introduces Stock Options 2025A Siili Solutions Plc has announced an exciting opportunity for its employees through a recently resolved stock options plan. This initiative is designed to enhance employee engagement and promote investment in the company’s future. The board made this decision on December 19, 2024, leveraging the authority granted by the...

Continue Reading
Akeso Initiates Phase III Trial of Ivonescimab for Cancer Care

Updated Category News Views 483

Akeso Begins Phase III Clinical Trial for Ivonescimab Akeso, Inc. (9926.HK) has exciting news as it announces the enrollment of its first patient in a pivotal Phase III clinical trial for ivonescimab, a revolutionary cancer treatment. This trial focuses on the use of ivonescimab, combined with chemotherapy, to address the challenging cases of unresectable locally advanced...

Continue Reading